CLA-2-13:OT:RR:NC:N5:231
Mr. Jooyong Paek
Gin Health Care
101-1902, 91, Jijedongsak 1-ro
Pyeongtaek-si 18026
South Korea
RE: The tariff classification of Red Ginseng Powder from South Korea
Dear Mr. Paek:
In your letter, dated September 26, 2025, you requested a tariff classification ruling.
The subject merchandise is Red Ginseng Powder that is marketed as Korean Red Ginseng Powder Gold. The
product is made from fresh ginseng roots that are steamed, dried, ground, and packaged in an inner vinyl bag
containing 300 grams and enclosed in an outer paper box. For preparation, the consumer is instructed to mix
2 grams of the powder into hot or warm water. After dissolution, the tea can be served. The product is
intended for retail sale through Amazon.
The applicable subheading for the Red Ginseng Powder will be 1302.19.4120, Harmonized Tariff Schedule
of the United States (HTSUS), which provides for: “Vegetable saps and extracts; pectic substances,
pectinates and pectates; agar-agar and other mucilages and thickeners, whether or not modified, derived from
vegetable products: Vegetable saps and extracts: Other: Ginseng; substances having anesthetic, prophylactic
or therapeutic properties: Other: Ginseng.” The rate of duty will be 1.0 percent ad valorem.
Effective April 5, 2025, Executive Orders implemented “Reciprocal Tariffs.” All imported merchandise
must be reported with either the Chapter 99 provision under which the reciprocal tariff applies or one of the
Chapter 99 provisions covering exceptions to the reciprocal tariffs. At this time, products of South Korea
will be subject to an additional ad valorem rate of duty of 15 percent. At the time of entry, you must report
the Chapter 99 heading applicable to your product classification, i.e. 9903.02.56, in addition to subheading
1302.19.4120, HTSUS, listed above.
The tariffs and additional duties cited above are current as of this ruling’s issuance. Duty rates are provided
for your convenience and are subject to change. The text of the most recent HTSUS and the accompanying
duty rates are provided at https://hts.usitc.gov/.
The holding set forth above applies only to the specific factual situation and merchandise description as
identified in the ruling request. This position is clearly set forth in Title 19, Code of Federal Regulations
(CFR), Section 177.9(b)(1). This section states that a ruling letter is issued on the assumption that all of the
information furnished in the ruling letter, whether directly, by reference, or by implication, is accurate and
complete in every material respect. In the event that the facts are modified in any way, or if the goods do not
conform to these facts at time of importation, you should bring this to the attention of U.S. Customs and
Border Protection (CBP) and submit a request for a new ruling in accordance with 19 CFR 177.2.
Additionally, we note that the material facts described in the foregoing ruling may be subject to periodic
verification by CBP.
This merchandise is subject to The Public Health Security and Bioterrorism Preparedness and Response Act
of 2002 (The Bioterrorism Act), which is regulated by the Food and Drug Administration (FDA).
Information on the Bioterrorism Act can be obtained by calling the FDA at 301-575-0156, or at the Web site
www.fda.gov/oc/bioterrorism/bioact.html.
This ruling is being issued under the provisions of Part 177 of Title 19 of the Code of Federal Regulations
(19 C.F.R. Part177).
A copy of the ruling or the control number indicated above should be provided with the entry documents
filed at the time this merchandise is imported. If you have any questions regarding the ruling, please contact
National Import Specialist Ekeng Manczuk at [email protected].
Sincerely,
(for)
Evan Conceicao
Designated Official Performing the Duties of the Division Director
National Commodity Specialist Division